HHealth Read More EULAR 2026 highlights rising comorbidity risks in rheumatic diseaseJune 4, 2026 People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases…
SScience Read More Why astronauts may face a hidden blood clot risk in space |March 17, 2026 As we explore more of the universe, the physical impacts of living in microgravity continue to be one…
HHealth Read More Oral anticoagulation for adults with atrial fibrillation or venous thromboembolismDecember 15, 2025 [Music] Welcome to the Australian Prescriber Podcast. An independent, no-nonsense podcast for busy health professionals. Hello and welcome…
HHealth Read More Improving diagnosis, treatment and follow-up care for pulmonary embolismOctober 31, 2025 Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people…
HHealth Read More Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factorsSeptember 1, 2025 Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
HHealth Read More COVID-19 ages arteries prematurely with women most affectedAugust 20, 2025 A major international study finds COVID-19 survivors, especially women, face signs of accelerated vascular aging, yet early evidence…